Código QR (código de barras bidimensional)

Recent advances in triple negative breast cancer: the immunotherapy era

Abstract Background Several accomplishments have been achieved in triple-negative breast cancer (TNBC) research over the last year. The phase III IMpassion130 trial comparing chemotherapy plus atezolizumab versus chemotherapy plus placebo brought breast cancer into the immunotherapy era. Nevertheles...

Fuld beskrivelse

Na minha lista:
Principais autores: Antonio Marra, Giulia Viale, Giuseppe Curigliano
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2019-05-01
Serier:BMC Medicine
Fag:
Triple-negative breast cancer
Immunotherapy
PD-L1
Biomarkers
Checkpoint inhibitors
Online adgang:http://link.springer.com/article/10.1186/s12916-019-1326-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker